These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Induction of nonspecific x-irradiation-resistant suppressor cell activity in vivo and prolongation of vascularized allograft survival by SK&F 105685, a novel immunomodulatory azaspirane. Schmidbauer G; Hancock WW; Badger AM; Kupiec-Weglinski JW Transplantation; 1993 Jun; 55(6):1236-43. PubMed ID: 8516808 [TBL] [Abstract][Full Text] [Related]
8. Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancement. Padberg WM; Lord RH; Kupiec-Weglinski JW; Williams JM; Di Stefano R; Thornburg LE; Araneda D; Strom TB; Tilney NL J Immunol; 1987 Sep; 139(6):1751-7. PubMed ID: 2957435 [TBL] [Abstract][Full Text] [Related]
9. Immune mechanisms in organ allograft rejection. V. Pivotal role of the cytotoxic-suppressor T cell subset in the rejection of heart grafts bearing isolated class I disparities in the inbred rat. Lowry RP; Forbes RD; Blackburn JH; Marghesco DM Transplantation; 1985 Nov; 40(5):545-50. PubMed ID: 3904091 [TBL] [Abstract][Full Text] [Related]
10. Behavior of helper T lymphocytes in cyclosporine-mediated long-term graft acceptance in the rat. Kupiec-Weglinski JW; Heidecke CD; Araujo JL; Abbud-Filho M; Towpik E; Araneda D; Strom TB; Tilney NL Cell Immunol; 1985 Jun; 93(1):168-77. PubMed ID: 3158407 [TBL] [Abstract][Full Text] [Related]
11. Identification of IL 2R+ T cells and macrophages within rejecting rat cardiac allografts, and comparison of the effects of treatment with anti-IL 2R monoclonal antibody or cyclosporin. Hancock WW; Lord RH; Colby AJ; Diamantstein T; Rickles FR; Dijkstra C; Hogg N; Tilney NL J Immunol; 1987 Jan; 138(1):164-70. PubMed ID: 3097143 [TBL] [Abstract][Full Text] [Related]
12. Regulation of rat B cell responses by T cell subsets and interleukin 2. Rosenberg JS; Gilman SC; Feldman JD J Immunol; 1982 Sep; 129(3):996-1001. PubMed ID: 6809819 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells. Pearce NW; Spinelli A; Gurley KE; Dorsch SE; Hall BM J Immunol; 1989 Jul; 143(2):499-506. PubMed ID: 2472441 [TBL] [Abstract][Full Text] [Related]
14. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Shimomura K; Hardy MA; Oluwole SF Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739 [TBL] [Abstract][Full Text] [Related]
15. T cell synergy in the primary MLR: proliferative kinetics, effector cell generation, and IL 2 production. Salomon DR; Cohen DJ; Williams JM; Carpenter CB J Immunol; 1984 Dec; 133(6):3075-83. PubMed ID: 6238093 [TBL] [Abstract][Full Text] [Related]
16. Immune mechanisms in organ allograft rejection. III. Cellular and humoral immunity in rejection of organ allografts transplanted across MHC subregion disparity RT1.B (RT1.D). Lowry RP; Gurley KE Transplantation; 1983 Oct; 36(4):405-11. PubMed ID: 6353708 [TBL] [Abstract][Full Text] [Related]
17. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. Dai Z; Konieczny BT; Baddoura FK; Lakkis FG J Immunol; 1998 Aug; 161(4):1659-63. PubMed ID: 9712028 [TBL] [Abstract][Full Text] [Related]
18. Identification of profound peripheral T lymphocyte immunodeficiencies in the spontaneously diabetic BB rat. Elder ME; Maclaren NK J Immunol; 1983 Apr; 130(4):1723-31. PubMed ID: 6220066 [TBL] [Abstract][Full Text] [Related]